Today's Portrait Highlights

Vilnius University Life Sciences Center

Vilnius University (VU) is the largest Lithuanian education and scientific institution. Research in Life and Health Sciences at VU is carried out in the Centre of Life Sciences. Research focus in the Centre of Life Sciences: gene editing technologies, like CRISPR Cas; nucleic acid and protein technologies, molecular diagnostics; drug design; droplet microfluidics technology; next generation epigenomics; biocatalyzers; lipid systems and membrane proteins; brain studies, like recording and analysis of physiological and psychophysiological parameters, also parameters of EEG, ECG, EDA, eye movements, psychological tests, steroid hormone concentration. Most of the Centre of Life Sciences laboratories are working as open access laboratories. Keywords: biomedicine; gene editing; epigenomics; biocatalyzers; diagnostic test systems; brain studies

Cure4You

A Digital platform for driving efficient business and clinical practice outcome. A Danish patient engagement company with leading market share in Denmark and serving almost 1.8 million patient lives. Platform and patient mobile apps support data-driven, protocol-based patient management, targeting: digital treatment plans; procedural specialties; chronic conditions; programmatic therapies. The platform delivers clinical awareness of targeted patient health factors to both patients and providers, drives patient compliance, and provides clinical team oversight and efficient remote engagement.

BonAlive Biomaterials Ltd

BonAlive Biomaterials Ltd is a privately held Class III medical device manufacturer that is based in Finland. We manufacture bioactive glass S53P4 based products for bone regeneration and septic bone surgery. For the past 15 years our products have shown unmatched clinical performance in orthopedic and trauma surgery, as well as in spine surgery. At BonAlive we are passionate about improving patient outcome. By providing well-proven and safe bone regeneration products to surgeons world-wide we also save operation costs and time. Our vision is to become the world-leader in providing synthetic biomaterial solutions for the treatment of chronically infected bone.